기본 정보
- 표준 SMILES
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(COC(C)=O)CS[C@H]12)c1csc(N)n1.[Na+]- InChIKey
AZZMGZXNTDTSME-JUZDKLSSSA-M- 분자식
- C16H16N5NaO7S2
- 평균 분자량
- 477.5 g/mol
- 단동위원소 질량
- 477.03888413
개요
Cefotaxime sodium is a cephalosporin organic sodium salt having acetoxymethyl and [2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino side-groups. It contains a cefotaxime(1-).
이름 및 식별자
- 우선 이름
- Cefotaxime Sodium
- IUPAC
- sodium (6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 현지명
- 세포탁심 나트륨
- 영어명
- Cefotaxime sodium
- 분자식
- C16H18N5NaO7S2
- 분자량
- 479.46
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
64485-93-4- PubChem CID
- 10695961
- DTXSID
DTXSID4046991- ChEMBL
CHEMBL1010- ChEBI
CHEBI:3498- UNII
- 258J72S7TZ
- EC Number
- 264-915-9
물성
구조 계산 물성
- 극성 표면적
- 230 Ų
- 수소 결합 공여자 수
- 2
- 수소 결합 수용자 수
- 12
- 회전 가능 결합 수
- 8
- 무거운 원자 수
- 31
- 형식 전하
- 0
- 복잡도
- 839
실험 및 물리화학적 성질
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
물리화학적 성질
- 녹는점
- 162 · 162-163 C
- 굴절률
- 61 ° · 61 ° (C=1, H2O)
- 저장 조건
- 2 · Keep in dark place,Inert atmosphere,2-8°C
- 용해도
- 2 O: · H2O: pH 4.3-6.2의 수용액은 2-8 ℃에서 최대 3주 동안 안정합니다.
- 물리적 상태
- 가루
- 색상
- 흰색에서 노란색으로
- 수소이온지수(pH)
- pH(100g/l, 25℃) : 4.5~6.5
- 수용성
- 물에 용해됩니다.
- Merck
- 14 · 14,1933
- BRN
- 5711411 · 5711411
- 안정성
- 안정적인. 강한 산화제와 호환되지 않습니다.
- InChIKey
- ACGQSCNTUWPWNB-RRVHIMMXNA-N
- SMILES
- C(C1=C(CS[C@]2([H])[C@H](NC(=O)/C(/C3=CSC(N)=N3)=N\OC)C(=O)N12)COC(=O)C)(=O)O.[NaH] |&1:5,7,r|
화학적 성질
White to pale yellow crystalline powder
안전 및 규제
GHS 분류
GHS Classification
Danger
H317 (99.2%): May cause an allergic skin reaction [Warning Sensitization, Skin]
P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 132 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
유해성 정보
독성 정보
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Cefotaxime sodium
vLess-DILI-concern
5
Adverse reactions
DOI:10.1016/j.drudis.2016.02.015
안전 데이터
- wgk
- 2
- rtecs
- XI0250000
- HS 번호
- 29419000
- risk_code
- 42/43
- hazard_code
- Xn,Xi
- safety_code
- 22-36/37-60-45-37-24
- Hazard Classifications
- Resp. Sens. 1Skin Sens. 1
- 스토리지 클래스
- 11 - Combustible Solids
화학 및 산업
약리 정보
FDA Pharmacological Classification
CEFOTAXIME INJECTION
Cephalosporin Antibacterial [EPC]; Cephalosporins [CS]
응용 분야
개요Cefotaxime was synthesized by Hoechst and Roussel-Uclaf in 1977. It was the first derivative of cephalosporin to introduce the methoxyimino and aminothiazole groups at the 7 position of the cephem nucleus. Although it shows unexpectedly low oral absorption, its excellent activity against a wide range of gram-positive and gram-negative organisms, including Serratia, Enterobacter, Citrobacter, and anaerobes, guided research and development of the newer synthetic cephems, the so-called thirdgeneration cephalosporins.
용도Cefotaxime sodium salt acts as a beta-lactamase resistant antibiotic. It is used as an effective antibacterial against gram-negative bacteria, with the notable exception of pseudomonas and penicillin-resistant strains of streptococcus pneumoniae. It is used to treat infections of the bones, joints, skin, respiratory tract and blood stream.
일반 설명Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
상·하류 제품 정보
상류 원료
하류 제품
공급사50 곳
추가 설명
정의ChEBI: A cephalosporin organic sodium salt having acetoxymethyl and [2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino side-groups.
관련 반응
연결된 노트
불러오는 중…